Industry leaders with proven results

Greg Lucier founded Corza Medical in partnership with leading private equity firm GTCR to combine his 30+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities. Greg most recently served as Chairman and CEO at NuVasive, a global technology leader in minimally invasive spine and orthopedic surgery. Prior to that, he was Chairman and CEO at Life Technologies—formerly Invitrogen—which he grew into a global life sciences powerhouse that was acquired by Thermo Fisher Scientific for more than $15 billion. He spent the first part of his career with the General Electric—including GE Healthcare—in a variety of corporate officer and executive roles. Greg serves on several public and private company boards, including Catalent, Dentsply Sirona, Berkley Lights, Maravai LifeSciences, and Epic Sciences. Greg holds a Bachelor’s in Industrial Engineering from Pennsylvania State University and a Master’s in Business Administration from Harvard Business School.

Matt Bastardi has over 20 years of leadership experience in the medical device & diagnostics industry, having managed teams in sales, marketing, finance, operations, corporate development, and strategic planning. Prior to Corza Medical and Surgical Specialties, Matt was Senior Vice President, Corporate Development & Strategy for Accriva Diagnostics. Matt helped lead the transformation of Accriva Diagnostics resulting in the sale of the Company to Werfen. Earlier in his career, Matt was Vice President, Portfolio Management, Strategic Marketing & Business Development for Covidien. He started his career in M&A investment banking for Alex. Brown & Sons. Matt earned an MBA from the Kellogg School of Management at Northwestern University, and a B.S. from Georgetown University.

Tom Testa has over 30 years of leadership experience with the last 10 years focused on the medical device industry. Tom’s experience includes both senior financial and general management roles. Prior to joining Corza Medical, Tom was the Vice President and General Manager of Nordson Medical, which he joined following Nordson’s acquisition of the Vention Medical Advanced Technologies business, where he was President. Previously, Tom served as Chief Financial Officer for Vention Medical and GenTek, Inc, a diversified industrial holding company. Tom earned a BS in Chemical Engineering from the New Jersey Institute of Technology and an MBA in Finance from the Stern School of Business at New York University.

Victor has over 20 years of experience in the healthcare, medical device, and medical instrument industries. Prior to joining Corza Medical and Surgical Specialties Corporation, Victor was Vice President, Global Operations at Teleflex Medical, the medical device and instrument manufacturing division of Teleflex Corporation. During his career at Teleflex, Mr. Diaz led a staff of 4,200 and was responsible for the global manufacturing, procurement, distribution, and complete supply chain with 25 plants and 23 distribution centers in Europe, Asia, Latin America, and the United States. Previously, Victor served as Vice President of Manufacturing at both Kendall Healthcare, a subsidiary of Tyco Healthcare, and Tyco Healthcare Respiratory. Victor received a BA in Chemistry from the Universidad Autonoma de Baja, California.

Prior to joining Corza Medical and Surgical Specialties in 2019, Yong was VP and General Manager of Physiology, Cell and Molecular Instruments at Harvard Biosciences. Previously, he served as Vice President of Global Marketing and Americas Sales at Beaver-Visitec International, a company combining the ophthalmic business units from Becton Dickinson (BD) and Medtronic. Earlier in his career, Yong served in progressive positions at BD, including Director of Global Marketing & U.S. Sales and at Eli Lilly & Company where he was the Marketing Manager, Global Life Sciences Market & Greater China Region. Yong holds an MBA from the MIT Sloan School of Management, a Master’s of Science in environmental science & engineering from Northeastern University and a Bachelor’s of Science in biochemistry from Peking University.

Brian Berning brings 20+ years of strategic leadership to Corza Medical, where he leverages his expertise in M&A, finance, and operations. Brian most recently served as the CFO at GreatCall, the leading provider of connected health solutions for seniors. He successfully guided the company through its acquisition by GTCR in 2017 and ultimate sale to Best Buy a year later for $800 million. Previously, as CFO at Human Longevity, a genomics and cellular therapy company, Brian helped raise over $300 million and establish global operations. Earlier in his career, Brian served as SVP of Finance at LPL Financial. Brian began his career with Ernst & Young, LLP where he earned his CPA. Brian holds a Bachelor’s in Business Administration from San Diego State University and a Master’s in Accounting from the University of Southern California.